|Eros International Plc -- USA Stock|| |
USD 13.2 0.7 5.04%
Analysis of Eros International manpower and management performance can provide insight into Eros International stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Eros International Plc future performance. Additionally see Investing Opportunities
Eros International Management Effectiveness
The company has return on total asset (ROA)
of 1.23 %
which means that it generated profit of $1.23 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE)
of 1.35 %
meaning that it created $1.35 on every $100 dollars invested by stockholders.
Eros International Profit Margins
The company has Profit Margin (PM) of 1.5 %
which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 10.06 %
which suggests for every 100 dollars of sales it generated a net operating income of 0.1.
Eros International Stakeholders
Eros International employes about 544 people. The company is managed by 17 executives with total tenure of roughly 75 years, averanging almost 4.0 years of service per executive having 32.0 employee per reported executive.
Eros International Plc
|Quarterly Estimate||0.03||June 27, 2017|
normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
|Revenue Per Employee|| 465.1 K|
|Revenue Per Executive|| 14.9 M|
|Net Income Per Employee|| 7 K|
|Net Income Per Executive|| 224.1 K|
|Working Capital Per Employee|| 152.2 K|
|Working Capital Per Executive|| 4.9 M|
Eros International Plc is rated # 5
in number of employees category among related companies. The total workforce
industry is currently estimated at about 10,693. Eros International holds roughly 544 in number of employees claiming about 5% of equities under Entertainment industry.